Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about LEGN
Recent news which mentions LEGN
< Previous
1
2
3
4
Next >
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
June 17, 2024
Tickers
JNJ
LEGN
Tags
Movers
Benzinga
Stories That Matter
From
Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
June 09, 2024
Tickers
ACLS
AGIO
HALO
IRTC
Tags
Top Stories
News
NUVL
From
Benzinga
Unveiling 18 Analyst Insights On Legend Biotech
June 04, 2024
Tickers
LEGN
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
May 14, 2024
Tickers
LEGN
Tags
Market News
Benzinga
LEGN
From
Benzinga
LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024
May 13, 2024
Tickers
LEGN
Tags
NASDAQ:LEGN
LEGN
Earnings Reports
From
InvestorPlace
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
April 19, 2024
Tickers
BMY
GILD
JNJ
LEGN
Tags
Penny Stocks
JNJ
Health Care
From
Benzinga
Analyst Ratings For Legend Biotech
April 17, 2024
Tickers
LEGN
Tags
LEGN
Benzinga
Market News
From
Benzinga
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
April 08, 2024
Tickers
JNJ
LEGN
NEWS
NVS
Tags
Equities
Large Cap
News
From
Benzinga
Unveiling 9 Analyst Insights On Legend Biotech
April 01, 2024
Tickers
LEGN
Tags
Benzinga
LEGN
Market News
From
Benzinga
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
March 20, 2024
Tickers
ASIA
BMY
JNJ
LEGN
Tags
contributors
JNJ
Benzinga
From
Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
March 18, 2024
Tickers
BMY
JNJ
LEGN
NEWS
Tags
Market News
BMY
why it's moving
From
Benzinga
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
Tickers
BMY
JNJ
LEGN
NEWS
Tags
Large Cap
News
Health Care
From
Benzinga
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
March 13, 2024
Tickers
BGNE
CLOV
HCM
LEGN
Tags
YMM
LEGN
Top Gainers
From
Benzinga
Earnings Scheduled For March 11, 2024
March 11, 2024
Tickers
ALTO
ASAN
ASRT
AVO
Tags
SND
CASY
BLDP
From
Benzinga
Earnings Preview: Legend Biotech
March 08, 2024
Tickers
LEGN
Tags
Market News
LEGN
Benzinga
From
Benzinga
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
March 07, 2024
Tickers
ACLX
BMY
GILD
JNJ
Tags
ACLX
Analyst Ratings
BMY
From
Benzinga
What 4 Analyst Ratings Have To Say About Legend Biotech
March 07, 2024
Tickers
LEGN
Tags
Market News
Benzinga
LEGN
From
Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers
AZN
BMY
GILD
GRCL
Tags
Stories That Matter
Benzinga
Biotech
From
Benzinga
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
January 10, 2024
Tickers
ASIA
BABA
BGNE
CHIR
Tags
#ChinaSlowdown
Benzinga
ETFs
From
Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
Tickers
ACLX
JNJ
LEGN
NEWS
Tags
SRPT
ACLX
Market News
From
Benzinga
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
December 29, 2023
Tickers
ALNY
ARWR
IBB
LEGN
Tags
Expert Ideas
Biotech
Benzinga
From
Benzinga
Key Takeaways From Legend Biotech Analyst Ratings
December 19, 2023
Tickers
LEGN
Tags
Market News
LEGN
Benzinga
From
Benzinga
Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say
December 11, 2023
Tickers
ACLX
JNJ
LEGN
Tags
General
LEGN
Briefs
From
Benzinga
Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment
November 20, 2023
Tickers
BMY
JNJ
LEGN
SPX
Tags
TSVT
JNJ
SPX
From
MarketWatch
Earnings Scheduled For November 20, 2023
November 20, 2023
Tickers
A
BLRX
BRBR
CENT
Tags
TCOM
GTEC
CENT
From
Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
Tickers
CVRX
JNJ
LEGN
NVS
Tags
JNJ
Recent Press Releases
LEGN
From
Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
October 18, 2023
Tickers
JNJ
LEGN
Tags
Analyst Color
Market News
Analyst Ratings
From
Benzinga
Analyst Ratings for Legend Biotech
October 18, 2023
Tickers
LEGN
Tags
Market News
Benzinga
LEGN
From
Benzinga
The Latest Analyst Ratings for Legend Biotech
August 16, 2023
Tickers
LEGN
Tags
LEGN
Benzinga
Market News
From
Benzinga
3 Biotech Stocks That Analysts Are Drooling Over
August 07, 2023
Tickers
CRSP
LEGN
ROIV
Tags
Stocks to Buy
ROIV
NASDAQ:LEGN,NASDAQ:ROIV,NASDAQ:CRSP
From
InvestorPlace
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.